The global Gaucher and Pompe diseases enzyme replacement therapy (ERT) market is poised for robust growth, with a projected valuation rising from USD 3.3 billion in 2023 to USD 6.2 billion by 2033. The market is expected to expand at a compound annual growth rate (CAGR) of 6.6% during the forecast period, driven by advancements …